Cardiac markers in the early diagnosis and management of patients with acute coronary syndrome

Sultan Qaboos University Medical Journal

Volumn 9, Issue 3, 2009, Pages 231-246

  Al Hadi, Hafidh A ^a   Fox, Keith A ^b  

^a SULTAN QABOOS UNIVERSITY HOSPITAL   (Oman)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

ACS; Acute coronary syndromes; Acute myocardial infarction; AMI; Cardiac markers; Chest pain; Non ST elevation myocardial infarction; NSTEMI

Indexed keywords

EID: 84885862453     PISSN: 2075051X     EISSN: 20750528     Source Type: Journal    
DOI: None     Document Type: Review

References (100)

1. Sans S, Kesteloot H, Kromhout D. The burden of cardiovascular disease mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe. Eur Heart J 1997; 18:1231-48.
2. Ericsson CG, Lindvall B, Olsson G. Trends in coronary care. A retrospective study of patients with myocardial infarction treated in coronary care units. Acta Med Scand 1988; 224:507-13.
3. Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization Task Force on Standardization of Clinical Nomenclature. Circulation 1979; 59:607-9.
4. Alpert JS, Thygesen K. Myocardial Infarction Redefined - A consensus document of the joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of Myocardial Infarction. Eur Heart J 2000; 21:1502-13.
5. Cohn PF. Silent myocardial ischemia. Ann Intern Med 1989; 109:312-17.
6. Gibler WB, Lewis LM, Erb RE, Makens PK, Kaplan BC, Vaughan RH, et al. Early detection of acute myocardial infarction in patients presenting with chest pain and nondiagnostic ECG’s: serial CK-MB sampling in the emergency department. Ann Emerg Med 1990; 19:1359-66.
7. Stark ME, Vacek JL. The initial electrocardiogram during admission for myocardial infarction. Use as a predictor of clinical course and facility utilization. Arch Intern Med 1987; 147:843-6.
8. Adams JE 3rd, Abendschein DR, Jaffe AS. Biochemical markers of myocardial injury. Is MB creatine kinase the choice for the 1990s? Circulation 1993; 88:750-63.
9. Hedges JR, Rouan GW, Toltzis R, Goldstein-Wayne B, Stein EA. Use of cardiac enzymes identifies patients with acute myocardial infarction otherwise unrecognized in the emergency department. Ann Emerg Med 1987; 16:248-52.
10. Van Blerk M, Maes V, Huyghens L, Derde MP, Meert R, Gorus FK. Analytical and clinical evaluation of creatine kinase MB mass assay by IMx: comparison with MB isoenzyme activity and serum myoglobin for early diagnosis of myocardial infarction. Clin Chem 1992; 38:2380-6.
11. De Winter RJ, Koster RW, Sturk A, Sanders GT. Value of myoglobin, troponin T, and CK-MB mass in ruling out an acute myocardial infarction in the emergency room. Circulation 1995; 92:3401-7.
12. Apple FS, Henry TD, Berger CR, Landt YA. Early monitoring of serum cardiac troponin I for assessment of coronary reperfusion following thrombolytic therapy. Am J Clin Pathol 1996; 105:6-10.
13. Henderson AR, Bhayana V. A modest proposal for the consistent presentations of ROC plots in clinical chemistry. Clin Chem 1995; 41:1205-6.
14. Wu AHB. Introduction to coronary artery disease (CAD) and Biochemical Markers. In: Wu AHB, Ed. Cardiac Markers. Totowa, NJ: Human Press Inc 1998. pp. 3-20.
15. Perryman MB, Strauss AW, Buettner TL, Roberts R. Molecular heterogeneity of creatine kinase isoenzymes. Biochim Biophys Acta 1983; 747:284-90.
16. Duma RJ, Seigel AL. Serum creatine phosphokinase in acute myocardial infarction. Arch Intern Med 1965; 115:443-51.
17. Pierce GF, Jaffe AS. Increased creatine kinase MB in the absence of acute myocardial infarction. Clin Chem 1986; 32:2044-51.
18. Wu AHB. Creatine Kinase, Isoenzymes, and variants In: Wu AHB, Ed. Cardiac Markers. Totowa, NJ: Humana Press Inc, 1998. pp.113-20.
19. Sasse EA, Madiedo G, Kopenski W. Evaluation of Abbott IMx: CK-MB Immunoassay. Clin Chem 1990; 36:1858-9.
20. Delanghe JR, De Mol AM, De Buyzere ML, De Scheerder IK, Weime RJ. Mass concentration and activity concentration of creatine kinase isoenzyme MB compared in serum after acute myocardial infarction. Clin Chem 1990; 36:149-53.
21. Bakker AJ, Gorgels JP, van Vlies B, Haagen FD, Smits R. The mass concentrations of serum troponin T and creatine kinase-MB are elevated before creatine kinase and creatine kinase-MB activities in acute myocardial infarction. Eur J Clin Chem 1993; 31:715-24.
22. Venta R, Geijo SA, Sanchez AC, Bao CG, Bartolome LA, Casares G, et al. IgA-CK-BB complex with CK-MB electrophoretic mobility can lead to erroneous diagnosis of acute myocardial infarction. Clin Chem 1989; 35:2003-8.
23. Irvin RG, Cobb FR, Roe CR. Acute myocardial infarction and MB creatine phosphokinase. Relationship between onset of symptoms of infarction and appearance and disappearance of enzyme. Arch Intern Med 1980; 140:329-34.
24. Gibler WB, Young GP, Hedges JR, Lewis LM, Smith MS, Carleton SC, et al. Acute myocardial infarction in chest pain patients with nondiagnostic ECGs: Serial CK-MB sampling in the emergency department. The Emergency Medicine Cardiac Research Group. Ann Emerg Med 1992; 21:504-12.
25. Ravkilde J, Hansen AB, Horder M, Jorgensen PJ, Thygesen K. Risk stratification in suspected acute myocardial infarction based on a sensitive immunoassay for serum creatine kinase isoenzyme MB. A 2.5 year follow-up study in 156 consecutive patients. Cardiology 1992; 80:143-51.
26. Seo H, Miyazaki S, Furuno T. Creatine Kinase-MB protein mass is a better indicator for the assessment of acute myocardial infarction in the lower range of creatine kinase level. Jpn Heart J 1993; 34:717-27.
27. Pettersson T, Ohlsson O, Tryding N. Increased CK-MB (mass concentration) in patients without traditional evidence of acute myocardial infarction. A risk indicator of coronary death. Eur Heart J 1992; 13:1387-92.
28. Ravkilde J, Nissen H, Mickley H, Andersen PE, Thayssen P, Horder M. Cardiac troponin-T and CK-MB mass release after visually successful percutaneous transluminal coronary angioplasty in stable angina pectoris. Am Heart J 1994; 127:13-20.
29. Abbas SA, Glazier JJ, Wu AH, Dupont C, Green SF, Pearsall LA, et al. Factors associated with the release of cardiac troponin T following percutaneous transluminal coronary angioplasty. Clin Cardiol 1996; 19:782-86.
30. Sasse EA, Madiedo G, Kopenski W. Evaluation of Abbott IMx: CK-MB Immunoassay. Clin Chem 1990; 36:1858-9.
31. Wevers RA, Delsing M, Klein Gebbink JA, Soons JB. Post-synthetic changes in creatine kinase isoenzymes (EC 2.7.3.2). Clin Chim Acta 1978; 86:323-7.
32. Hendriks D, Soons J, Scharpe S, Wevers R, van Sande M, Holmquist B. Identification of the carboxypeptidase responsible for the post-synthetic modification of creatine kinase in human serum. Clin Chim Acta 1988; 172:253-60.
33. Hossein-Nia M, Kallis P, Brown PA, Chester MR, Kaski JC, Murday AJ, et al. Creatine kinase MB isoforms: sensitive markers of ischemic myocardial disease. Clin Chem 1994; 40:1265-71.
34. Puleo PR, Guadagno PA, Roberts R, Scheel MV, Marian AJ, Churchill D, et al. Early diagnosis of acute myocardial infarction based on assay for subforms of creatine kinase-MB. Circulation 1990; 82:759-64.
35. Puleo PR, Meyer D, Wathen C, Tawa CB, Wheeler S, Hamburg RJ, et al. Use of a rapid assay of subforms of creatine kinase-MB to diagnose or rule out acute myocardial infarction. N Engl J Med 1994; 331:561-6.
36. Zimmerman J, Fromm R, Meyer D, Boudreaux A, Wun CC, Smalling R, et al. Diagnostic Marker Cooperative Study for the diagnosis of myocardial infarction. Circulation 1999; 99:1671-7.
37. Laurino JP, Bender EW, Kessimian N, Chang J, Pelletier T, Usategui M. Comparative sensitivities and specificities of mass measurements of CK-MB2, CK- MB, and myoglobin for diagnosing acute myocardial infarction. Clin Chem 1996; 42:1454-9.
38. Bhayana V, Cohoe S, Leung FY, Jablonsky G, Henderson AR. Diagnostic evaluation of creatine kinase-2 mass and creatine kinase-3 and -2 isoform ratios in early diagnosis of acute myocardial infarction. Clin Chem 1993; 39:488-95.
39. Davies J, Reynolds T, Penney MD. Creatine kinase isoforms: investigation of inhibitors of in vitro degradation and establishment of a reference range. Ann Clin Biochem 1992; 29:202-5.
40. Schweisfurth H, Pickert E, Gramer E, Reiners C. Alterations of carboxypeptidases N activities in patients with thyroid dysfunction. Clin Biochem 1987; 20:43-6.
41. Wu AH, Wang XM, Gornet TG, Ordonez-Llanos J. Creatine kinase MB isoforms in patients with skeletal muscle injury: ramifications for early detection of acute myocardial infarction. Clin Chem 1992; 38:2396-400.
42. Van Nieuwenhoven FA, Kleine AH, Wodzig KW, Hermens WT, Kragten HA, Maessen JG, et al. Discrimination between myocardium and skeletal muscle injury by assessment of the plasma ratio of myoglobin over fatty acid-binding protein. Circulation 1995; 92:2848-54.
43. Kagen L, Scheidt S, Roberts L, Porter A, Paul H. Myoglobinemia following acute myocardial infarction. Am J Med 1975; 58:177-82.
44. Bhayana V, Cohoe S, Pellar TG, Jablonsky G, Henderson AR. Combination (multiple) testing for myocardial infarction using myoglobin, creatine kinase-2 (mass), and troponin T. Clin Biochem 1994; 27:395-406.
45. Vaidya HC. Myoglobin: an early biochemical marker for the diagnosis of acute myocardial infarction. J Clin Immunoassay 1994; 17:35-9.
46. Varki AP, Roby DS, Watts H, Zatuchni. Serum myoglobin in acute myocardial infarction: A clinical study and review of the literature. Am Heart J 1978; 96:680-8.
47. Collins R, Tucker J. Myoglobin and CK-MB for the diagnosis of acute myocardial infarction in emergency room patients. Clin Chem 1991; 37:978.
48. Anderson HV, Willerson JT. Thrombolysis in acute myocardial infarction. N Engl J Med 1993; 329:703-9.
49. Ishii J, Nomura M, Ando T, Hasegawa H, Kimura M, Kurokawa H, et al. Early detection of successful coronary reperfusion based on serum myoglobin concentration; comparison with serum creatine kinase isoenzyme MB activity. Am Heart J 1994; 128:641-8.
50. Zabel M, Honloser SH, Koster W, Prinz M, Kasper W, Just H. Analysis of creatine kinase, CK-MB, myoglobin and troponin T time-activity curves for early assessment of coronary artery reperfusion after intravenous thrombolysis. Circulation 1993; 87:1542-50.
51. Miyata M, Abe S, Arima S, Nomoto K, Kawataki M, Ueno M, et al. Rapid diagnosis of coronary reperfusion by measurement of myoglobin level every 15 min in acute myocardial infarction. J Am Coll Cardiol 1994; 23:1009-15.
52. Glatz JF, Van Bilsen M, Paulussen RJ, Veerkamp JH, Van der Vusse GJ, Reneman RS, et al. Release of fatty acid-binding protein from isolated rat heart subjected to ischemia and reperfusion or to the calcium paradox. Biochim Biophys Acta 1988; 961:148-52.
53. Ishii J, Wang JH, Naruse H, Taga S, Kinoshita M, Kurokawa H, et al. Serum concentrations of myoglobin vs human heart-type cytoplasmic fatty acid-binding protein in early detection of acute myocardial infarction. Clin Chem 1997; 43:1372-8.
54. Alhadi HA, Fox KA. Do we need additional markers of myocyte necrosis: the potential value of heart fatty acid-binding protein. QJM 2004; 97:187-98.
55. Glatz JF, Van der Vusse GJ, Maessen JG, Van Dieijen-Visser MP, Hermens WT. Fatty acid-binding protein as marker of muscle injury: experimental finding and clinical application. Acta Anaesthesiol Scand Suppl 1997; 111:292-4.
56. Kleine AH, Glatz JF, Van Nieuwenhoven FA, Van der Vusse GJ. Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man. Mol Cell Biochem 1992; 116:155-62.
57. Bakker AJ, Koelemay MJ, Gorgels JP, van Vlies B, Smits R, Tijssen JG, et al. Failure of new biochemical markers to exclude acute myocardial infarction at admission. Lancet 1993; 342:1220-2.
58. Colli A, Jossa M, Pomar JL, Mestres CA, Gharli T. Heart fatty acid binding proteins in diagnosis of myocardial infarction: where do we stand now? Cardiology 2007; 108:4-10.
59. AlAnsari SE, Croal BL. Diagnostic value of heart fatty acid binding protein and myoglobin in patients admitted with chest pain. Ann Clin Biochem 2004; 41:391-6.
60. IIva T, Lund J, Poreta P, Mustonen H, Voipio-Pulkki LM, Eriksson S, et al. Early markers of myocardial injury: cTnI is enough. Clinica Chimica Acta 2009; 400:82-5.
61. Crisman TS, Claffey KP, Saouaf R, Hanspal J, Brecher P. Measurement of rat heart fatty acid-binding protein by ELISA. Tissue distribution, developmental changes and subcellular distribution. J Mol Cell Cardiol 1987; 19:23-31.
62. Gorski J, Hermens WT, Borawski J, Mysliwiec M, Glatz JF. Increased fatty acid-binding protein concentration in plasma of patients with chronic renal failure. Clin Chem 1997; 43:193-5.
63. Alhadi HA, William B, Fox KA. Serum level of heart fatty acid binding protein in patients with chronic renal failure. SQU Med J 2009; 9:311-13.
64. Van Nieuwenhoven FA, Kleine AH, Wodzig KW, Hermens WT, Kragten HA, Maessenn JG et al. Discrimination between myocardium and skeletal muscle injury by assessment of the plasma ratio of myoglobin over fatty acid-binding protein. Circulation 1995; 92:2848-54.
65. Sorichter S, Mair J, Kollar A, Pelsers MM, Puschendorf B, Glatz JF. Early assessment of exercise induced skeletal muscle injury using plasma fatty acid binding protein. Br J Sports Med 1998; 32:121-4.
66. Glatz JF, Van der Vusse GJ, Maessen JG, Van Dieijen-Visser MP, Hermens WT. Fatty acid-binding protein as marker of muscle injury: experimental finding and clinical application. Acta Anaesthesiol Scand Suppl 1997; 111:292-4.
67. Ishii J, Wang JH, Naruse H, Taga S, Kinoshita M, Kurokawa H et al. Serum concentrations of myoglobin vs human heart-type cytoplasmic fatty acid-binding protein in early detection of acute myocardial infarction. Clin Chem 1997; 43:1372-8.
68. Greaser ML, Gergely J. Purification and properties of the components from troponin. J Biol Chem 1973; 248:2125-33.
69. Wu AH, Feng YJ. Biochemical differences between cTnT and cTnI and their significance for diagnosis of acute coronary syndromes. Eur Heart J 1999; 19 Suppl: N25-N29.
70. Dhoot GK, Frearson N, Perry SV. Polymorphic forms of troponin T and Troponin C and their localization in striated muscle cell types. Exp Cell Res 1979; 122:339-50.
71. Katus HA, Remppis A, Looser S, Hallermeier K, Scheffold T, Kubler W. Enzyme linked immuno assay of cardiac troponin T for the detection of acute myocardial infarction in patients. J Mol Cell Cardiol 1989; 21:1349-53.
72. Muller-Bardorff M, Hallermayer K, Schroder A, Ebert C, Borgya A, Gerhardt W, et al. Improved troponin T ELISA specific for cardiac troponin T isoform: assay development and analytical and clinical validation. Clin Chem 1997; 43:458-66.
73. Gerhardt W, Ljungdahl L, Herbert A. Troponin T and CK-MB (mass) in early diagnosis of ischemic myocardial injury. The Helsingborg Study, 1992. Clin Biochem 1993; 26:231-40.
74. Wu AH, Valdes R Jr, Apple FS, Gornet T, Stone MA, Mayfield-Stokes S, et al. Cardiac troponin-T immunoassay for diagnosis of acute myocardial infarction. Clin Chem 1994; 40:900-7.
75. Hugenholtz PG. Unstable angina revisited once more. Eur Heart J 1986; 7:1010-15.
76. Ohman EM, Armstrong PW, Christenson RH, Granger CB, Katus HA, Hamm CW et al. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators. N Engl J Med 1996; 335:1333-41.
77. Jurlander B, Farhi ER, Banas JJ Jr, Keany CM, Balu D, Grande P, et al. Coronary angiographic findings and troponin T in patients with unstable angina pectoris. Am J Cardiol 2000; 85:810-14.
78. Lindahl B, Venge P, Wallentin L. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC Study Group. Circulation 1996; 93:1651-7.
79. Stubbs P, Collinson P, Moseley D, Greenwood T, Noble M. Prospective study of the role of cardiac troponin T in patients admitted with unstable angina. BMJ 1996; 13:262-4.
80. Schreiber TL, Rizik D, White C, Sharma GV, Cowlev M, Macina G, et al. Randomized trials of thrombolysis versus heparin in unstable angina. Circulation 1992; 86:1407-14.
81. Fox KA. Acute coronary syndromes: presentation-clinical spectrum and management. Heart 2000; 84:93-100.
82. Lindahl B, Venge P, Wallentin L. Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic treatment. Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group. J Am Coll Cardiol 1997; 29:43-8.
83. Li D, Jialal I, Keffer J. Greater frequency of increased cardiac troponin T than increased cardiac troponin I in patients with chronic renal failure. Clin Chem 1996; 42:114-15.
84. Needham DM, Shufelt KA, Tomlinson G, Scholey JW, Newton GE. Troponin I and T levels in renal failure patients without acute coronary syndrome: a systematic review of the literature. Can J Cardiol 2004; 20:1212-18.
85. Khan NA, Hemmelgarn BR, Tonell M, Thompson CR, Levin A. Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis. Circulation 2005; 112:3088-96.
86. Kobayashi S, Tanaka M, Tamura N, Hashimoto H, Hirose S. Serum cardiac troponin T in polymyositis/ dermatomyositis. Lancet 1992; 340:726.
87. Guest TM, Ramanathan AV, Tuteur PG, Schechtman KB, Ladenson JH, Jaffe AS. Myocardial injury in critically ill patients: a frequently unrecognized complication. JAMA 1995; 273:1945-9.
88. Grubb NR, Fox KA, Cawood P. Resuscitation from out-of-hospital cardiac arrest: implications for cardiac enzyme estimation. Resuscitation 1996; 33:35-41.
89. Lauer B, Niederau C, Kuhl U, Schannwell M, Pauschinger M, Strauer BE, et al. Cardiac troponin T in patients with clinically suspected myocarditis. J Am Coll Cardiol 1997; 30:1354-9.
90. Herman EH, Lipshultz SE, Rifai N, Zhang J, Papoian T, Yu ZX, et al. Use of cardiac troponin T levels as an indicator of doxorubicin-induced cardiotoxicity. Cancer Res 1998; 58:195-7.
91. Becattini C, Vedovati MC, Agnelli G. Prognostic value of troponin in acute pulmonary embolism: a meta-analysis. Circulation 2007; 116:427-33.
92. Agezew Y. Elevated serum cardiac troponin in non-acute coronary syndrome. Clin Cardiol 2009; 32:15-20.
93. Sasse S, Brand NJ, Kyprianou P, Dhoot GK, Wade R, Arai M, et al. Troponin I gene expression during human cardiac development and in end-stage heart failure. Circ Res 1993; 72:932-8.
94. Bodor GS, Porterfield D, Voss EM, Smith S, Apple FS. Cardiac troponin-I is not expressed in adult human skeletal muscle tissue. Clin Chem 1995; 41:1710-15.
95. Adams JE 3rd, Schechtman KB, Landt Y, Ladenson JH, Jaffe AS. Comparable detection of acute myocardial infarction by creatine kinase MB isoenzyme and cardiac troponin I. Clin Chem 1994; 40:1291-5.
96. Genser N, Mair J, Talasz H, Puschendorf B, Puschendorf B, Calzolari C, et al. Cardiac troponin I to diagnose percutaneous transluminal coronary angioplasty-related myocardial injury. Clin Chim Acta 1997; 265:207-17.
97. Galvani M, Ottani F, Ferrini D, Ladenson JH, Destro A, Baccos D, et al. Prognostic influence of elevated values of cardiac troponin I in patients with unstable angina. Circulation 1997; 95:2053-9.
98. Hunt AC, Chow SL, Shiu MF, Chilton DC, Cummins B, Cummins P. Release of creatine kinase-MB and cardiac specific troponin-I following percutaneous transluminal coronary angioplasty. Eur Heart J 1991; 12:690-4.
99. Kalla C, Raveh D, Algur N, Rudensky B, Yinnon AM, Ballan J. Incidence and significance of a positive troponin test in bacteremic patients without acute coronary syndrome. Am J Med 2008; 121:909-15.
100. Adams JE 3rd, Sicard GA, Allen BT, Bridwell KH, Lenke LG, Davilla-Roman VG, et al. Diagnosis of perioperative myocardial infarction with measurement of cardiac troponin I. N Engl J Med 1994; 330:670-4.